InnoCimAb Overview
- Year Founded
-
2014
- Status
-
Private
- Latest Deal Type
-
Joint Venture
- Financing Rounds
-
1
InnoCimAb General Information
Description
Operator of a biotech licensor platform intended for the sectors of biotechnology and pharmaceuticals. The company offers licensing, clinical development, and commercialization of monoclonal antibody-based treatments for its clients.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
- 21 Bukit Batok Crescent, WCEGA Tower
- Suite 11-70
- 658065
- Singapore
Corporate Office
- 21 Bukit Batok Crescent, WCEGA Tower
- Suite 11-70
- 658065
- Singapore
InnoCimAb Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
InnoCimAb Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
InnoCimAb FAQs
-
When was InnoCimAb founded?
InnoCimAb was founded in 2014.
-
Where is InnoCimAb headquartered?
InnoCimAb is headquartered in Singapore.
-
What industry is InnoCimAb in?
InnoCimAb’s primary industry is Biotechnology.
-
Is InnoCimAb a private or public company?
InnoCimAb is a Private company.
-
What is InnoCimAb’s current revenue?
The current revenue for InnoCimAb is .
-
Who are InnoCimAb’s investors?
Cimab and Innokeys have invested in InnoCimAb.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process